Vanderbilt Univeristy SC — Nashville, Tennessee

Vanderbilt Univeristy SC is a clinical research site located in Nashville, Tennessee, United States 37232.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Vanderbilt Univeristy SC has participated in 1 clinical trials.

Therapeutic areas: Advanced Solid Tumors With an Alteration of the PIK3CA Gene, Estrogen Receptor Positive Breast Cancer.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt Univeristy SC?

Vanderbilt Univeristy SC has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt Univeristy SC conducted?

Vanderbilt Univeristy SC has 1 clinical trials on record. Their work covers Advanced Solid Tumors With an Alteration of the PIK3CA Gene, Estrogen Receptor Positive Breast Cancer.

Is Vanderbilt Univeristy SC accredited by Crixeo Health?

Vanderbilt Univeristy SC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt Univeristy SC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.